Ovarian Cancers

Advances through International Research Cooperation (GINECO, ENGOT, GCIG)

Nonfiction, Health & Well Being, Medical, Specialties, Gynecology & Obstetrics, Oncology
Cover of the book Ovarian Cancers by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319321103
Publisher: Springer International Publishing Publication: October 17, 2016
Imprint: Springer Language: English
Author:
ISBN: 9783319321103
Publisher: Springer International Publishing
Publication: October 17, 2016
Imprint: Springer
Language: English

This book provides an overview of the latest developments in the concepts and management of ovarian cancer. The new data presented throughout opens the way to radically different therapeutic approaches. Surgery remains the core of ovarian cancer treatment, but its ultimate goal and the standard surgical procedure have evolved, giving rise to the question of how to label expert centers for debulking surgery. Neo-adjuvant chemotherapy is becoming more popular and is also a new field for testing novel drug combinations.

Over recent years, ovarian cancer management has embraced molecular biology. It is now more correct to talk about cancers of the ovary rather than ovarian cancer, since it is not a unique disease but several entities with different molecular drivers. The significant advances in drugs targeting the microenvironment or the tumor cell DNA repair mechanisms are presented in detail together with exciting future perspectives.

All these advances would not have been possible without collaborative groups such as the GINECO group in France and their integration in wider clinical research networks at the European (ENGOT) and international (GCIG) level.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides an overview of the latest developments in the concepts and management of ovarian cancer. The new data presented throughout opens the way to radically different therapeutic approaches. Surgery remains the core of ovarian cancer treatment, but its ultimate goal and the standard surgical procedure have evolved, giving rise to the question of how to label expert centers for debulking surgery. Neo-adjuvant chemotherapy is becoming more popular and is also a new field for testing novel drug combinations.

Over recent years, ovarian cancer management has embraced molecular biology. It is now more correct to talk about cancers of the ovary rather than ovarian cancer, since it is not a unique disease but several entities with different molecular drivers. The significant advances in drugs targeting the microenvironment or the tumor cell DNA repair mechanisms are presented in detail together with exciting future perspectives.

All these advances would not have been possible without collaborative groups such as the GINECO group in France and their integration in wider clinical research networks at the European (ENGOT) and international (GCIG) level.

More books from Springer International Publishing

Cover of the book Nanobotany by
Cover of the book Fanaticism, Racism, and Rage Online by
Cover of the book New Organizational Forms, Controls, and Institutions by
Cover of the book Information Security and Cryptology by
Cover of the book Chaos, Complexity and Leadership 2017 by
Cover of the book From Information to Smart Society by
Cover of the book Advances in Cryptology – CRYPTO 2018 by
Cover of the book Law, Politics and the Limits of Prosecuting Mass Atrocity by
Cover of the book Swarm Intelligence by
Cover of the book Heart Rate Variability Analysis with the R package RHRV by
Cover of the book Creating Organizational Value through Dialogical Leadership by
Cover of the book Social Media Shaping e-Publishing and Academia by
Cover of the book Posthumanism and Higher Education by
Cover of the book Battlefield Acoustics by
Cover of the book Introduction to the Analytic Hierarchy Process by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy